ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,528, issued on Jan. 27, was assigned to LG CHEM Ltd. (Seoul, South Korea).
"Anti-LILRB1 antibody and uses thereof" was invented by Yoon Aa Choi (Daejeon, South Korea), Jung A Kim (Daejeon, South Korea), Saem Jung (Daejeon, South Korea), Ji Hyun Lee (Daejeon, South Korea), Kyubong Na (Daejeon, South Korea), Yeonchul Kim (Daejeon, South Korea) and Han Byul Kim (Daejeon, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an anti-LILRB1 antibody having increased specificity for LILRB1, and to uses thereof. Specifically, provided are an anti-LILRB1 antibody or antigen-binding fragment thereof, and uses thereof in ...